My Unexpected Journey Back to Health
At 52, I never imagined I'd face lymphoma, three brain tumors, HIV progressing to AIDS, countless blood clots, and heart failure all within five years. Each diagnosis brought new medications, hospital stays, and the crushing reality of rapid weight gain from steroids, antiretrovirals, and limited mobility. Joint pain made movement feel impossible, and hormonal shifts from treatment turned my body into a stubborn fortress against weight loss. Yet today, I'm thriving on a GLP-1 regimen including semaglutide and tirzepatide. Here's exactly how I did it, drawing from the principles in my book The Resilient Body Protocol.
Why GLP-1s Became My Lifeline Despite Complex Conditions
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) do far more than suppress appetite. They reduce inflammation, improve insulin sensitivity, and support cardiovascular health—critical when you're managing heart failure and diabetes alongside obesity. In my case, after chemotherapy left me with 85 extra pounds and an A1C of 9.2, these medications helped me lose 62 pounds in 14 months while my ejection fraction improved from 35% to 52%. Blood pressure stabilized at 118/76 without extra meds. The key? Starting at micro-doses: 0.25mg semaglutide weekly, titrating slowly over 8 weeks while monitoring INR levels due to my clotting history.
Practical Strategies That Protected My Fragile Health
I never followed complex meal plans. Instead, I used a simple 16:8 intermittent fasting window adjusted for my HIV medications, focusing on 1.2g protein per kg body weight to preserve muscle—vital with joint pain and limited exercise. Walking 15 minutes after meals became my "gym," reducing postprandial glucose spikes by 28% on average. Hydration reached 100oz daily to counter constipation side effects, and I tracked electrolytes to prevent arrhythmias common in heart failure patients. Regular echocardiograms and viral load checks ensured the GLP-1s didn't interfere with my antiretroviral therapy. For brain tumor survivors, the cognitive clarity many report on tirzepatide was a welcome bonus; I experienced sharper focus within six weeks.
Lessons for Beginners Facing Similar Battles
If you've failed every diet and feel overwhelmed by conflicting advice, know this: GLP-1s aren't magic, but they reset metabolic signaling damaged by chronic illness. Insurance barriers are real—my program started with compounded semaglutide at $180/month until prior authorization cleared. Start conversations with your cardiologist and endocrinologist about combined therapy. In The Resilient Body Protocol, I outline a 4-phase approach: stabilize, reduce inflammation, rebuild metabolism, and maintain without burnout. My survival proves that even with AIDS-level immune compromise and multiple tumors, sustainable weight loss is possible. Focus on consistency over perfection; my average weekly loss was 1.1 pounds, but the health gains were exponential. Consult your care team before starting, monitor weekly, and celebrate non-scale victories like easier breathing and stable blood sugar.